Protocol to investigate the effect of cyclo-oxyganase (COX)-2 inhibition on reducing central sensitisation of pain in osteoarthritis.
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2013
At a glance
- Drugs Etoricoxib (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 12 Jul 2011 Status changed from completed to recruiting as reported by European Clinical Trials Database record.
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record).
- 01 Mar 2009 Status changed from recruiting to completed as reported by ISRCTN.